184 related articles for article (PubMed ID: 32073139)
1. MicroRNAs in gray and white matter multiple sclerosis lesions: impact on pathophysiology.
Teuber-Hanselmann S; Meinl E; Junker A
J Pathol; 2020 Apr; 250(5):496-509. PubMed ID: 32073139
[TBL] [Abstract][Full Text] [Related]
2. [Gray matter lesions and cognitive impairment in multiple sclerosis].
Kawachi I; Saji E; Nishizawa M
Rinsho Shinkeigaku; 2014; 54(12):1060-2. PubMed ID: 25672709
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes in the Pathogenesis of Multiple Sclerosis: An In Situ MicroRNA Study.
Rao VTS; Fuh SC; Karamchandani JR; Woulfe JMJ; Munoz DG; Ellezam B; Blain M; Ho MK; Bedell BJ; Antel JP; Ludwin SK
J Neuropathol Exp Neurol; 2019 Dec; 78(12):1130-1146. PubMed ID: 31665376
[TBL] [Abstract][Full Text] [Related]
4. Regulation of microglial TMEM119 and P2RY12 immunoreactivity in multiple sclerosis white and grey matter lesions is dependent on their inflammatory environment.
van Wageningen TA; Vlaar E; Kooij G; Jongenelen CAM; Geurts JJG; van Dam AM
Acta Neuropathol Commun; 2019 Dec; 7(1):206. PubMed ID: 31829283
[TBL] [Abstract][Full Text] [Related]
5. Tissue-resident memory T cells invade the brain parenchyma in multiple sclerosis white matter lesions.
Fransen NL; Hsiao CC; van der Poel M; Engelenburg HJ; Verdaasdonk K; Vincenten MCJ; Remmerswaal EBM; Kuhlmann T; Mason MRJ; Hamann J; Smolders J; Huitinga I
Brain; 2020 Jun; 143(6):1714-1730. PubMed ID: 32400866
[TBL] [Abstract][Full Text] [Related]
6. Transcript Profiles of Microglia/Macrophage Cells at the Borders of Chronic Active and Subpial Gray Matter Lesions in Multiple Sclerosis.
Chomyk A; Kucinski R; Kim J; Christie E; Cyncynatus K; Gossman Z; Chen Z; Richardson B; Cameron M; Turner T; Dutta R; Trapp B
Ann Neurol; 2024 May; 95(5):907-916. PubMed ID: 38345145
[TBL] [Abstract][Full Text] [Related]
7. Small heat shock proteins are induced during multiple sclerosis lesion development in white but not grey matter.
Peferoen LA; Gerritsen WH; Breur M; Ummenthum KM; Peferoen-Baert RM; van der Valk P; van Noort JM; Amor S
Acta Neuropathol Commun; 2015 Dec; 3():87. PubMed ID: 26694816
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA profiles of MS gray matter lesions identify modulators of the synaptic protein synaptotagmin-7.
Fritsche L; Teuber-Hanselmann S; Soub D; Harnisch K; Mairinger F; Junker A
Brain Pathol; 2020 May; 30(3):524-540. PubMed ID: 31663645
[TBL] [Abstract][Full Text] [Related]
9. Acute and chronic synaptic pathology in multiple sclerosis gray matter.
Vercellino M; Marasciulo S; Grifoni S; Vallino-Costassa E; Bosa C; Pasanisi MB; Crociara P; Casalone C; Chiò A; Giordana MT; Corona C; Cavalla P
Mult Scler; 2022 Mar; 28(3):369-382. PubMed ID: 34124960
[TBL] [Abstract][Full Text] [Related]
10. Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron.
Haider L; Simeonidou C; Steinberger G; Hametner S; Grigoriadis N; Deretzi G; Kovacs GG; Kutzelnigg A; Lassmann H; Frischer JM
J Neurol Neurosurg Psychiatry; 2014 Dec; 85(12):1386-95. PubMed ID: 24899728
[TBL] [Abstract][Full Text] [Related]
11. Multifaceted involvement of microglia in gray matter pathology in multiple sclerosis.
Tsouki F; Williams A
Stem Cells; 2021 Aug; 39(8):993-1007. PubMed ID: 33754376
[TBL] [Abstract][Full Text] [Related]
12. Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures.
Tripathi A; Pandit I; Perles A; Zhou Y; Cheng F; Dutta R
Ann Clin Transl Neurol; 2021 Jun; 8(6):1279-1291. PubMed ID: 33978322
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gray-matter multiple sclerosis lesions using double inversion recovery, diffusion, contrast-enhanced, and volumetric MRI.
Parra Corral MA; Govindarajan ST; Stefancin P; Bangiyev L; Coyle PK; Duong TQ
Mult Scler Relat Disord; 2019 Jun; 31():74-81. PubMed ID: 30951968
[TBL] [Abstract][Full Text] [Related]
14. Lesion Expansion in Experimental Demyelination Animal Models and Multiple Sclerosis Lesions.
Große-Veldmann R; Becker B; Amor S; van der Valk P; Beyer C; Kipp M
Mol Neurobiol; 2016 Sep; 53(7):4905-17. PubMed ID: 26363796
[TBL] [Abstract][Full Text] [Related]
15. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
Hojjat SP; Kincal M; Vitorino R; Cantrell CG; Feinstein A; Zhang L; Lee L; O'Connor P; Carroll TJ; Aviv RI
AJNR Am J Neuroradiol; 2016 Aug; 37(8):1454-61. PubMed ID: 27012299
[TBL] [Abstract][Full Text] [Related]
16. Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
Trapp BD; Vignos M; Dudman J; Chang A; Fisher E; Staugaitis SM; Battapady H; Mork S; Ontaneda D; Jones SE; Fox RJ; Chen J; Nakamura K; Rudick RA
Lancet Neurol; 2018 Oct; 17(10):870-884. PubMed ID: 30143361
[TBL] [Abstract][Full Text] [Related]
17. Cortical Gray Matter MR Imaging in Multiple Sclerosis.
Calabrese M; Castellaro M
Neuroimaging Clin N Am; 2017 May; 27(2):301-312. PubMed ID: 28391788
[TBL] [Abstract][Full Text] [Related]
18. Modeling the relationship among gray matter atrophy, abnormalities in connecting white matter, and cognitive performance in early multiple sclerosis.
Kuceyeski AF; Vargas W; Dayan M; Monohan E; Blackwell C; Raj A; Fujimoto K; Gauthier SA
AJNR Am J Neuroradiol; 2015 Apr; 36(4):702-9. PubMed ID: 25414004
[TBL] [Abstract][Full Text] [Related]
19. Spatial distribution of multiple sclerosis lesions in the cervical spinal cord.
Eden D; Gros C; Badji A; Dupont SM; De Leener B; Maranzano J; Zhuoquiong R; Liu Y; Granberg T; Ouellette R; Stawiarz L; Hillert J; Talbott J; Bannier E; Kerbrat A; Edan G; Labauge P; Callot V; Pelletier J; Audoin B; Rasoanandrianina H; Brisset JC; Valsasina P; Rocca MA; Filippi M; Bakshi R; Tauhid S; Prados F; Yiannakas M; Kearney H; Ciccarelli O; Smith SA; Andrada Treaba C; Mainero C; Lefeuvre J; Reich DS; Nair G; Shepherd TM; Charlson E; Tachibana Y; Hori M; Kamiya K; Chougar L; Narayanan S; Cohen-Adad J
Brain; 2019 Mar; 142(3):633-646. PubMed ID: 30715195
[TBL] [Abstract][Full Text] [Related]
20. Complement is activated in progressive multiple sclerosis cortical grey matter lesions.
Watkins LM; Neal JW; Loveless S; Michailidou I; Ramaglia V; Rees MI; Reynolds R; Robertson NP; Morgan BP; Howell OW
J Neuroinflammation; 2016 Jun; 13(1):161. PubMed ID: 27333900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
